Log in to search using one of your social media accounts:

 

FDA releases framework guidelines for regenerative med development
The FDA this week laid out guidelines for a new framework it’s implementing for the development and oversight of regenerative medicine products including novel cellular therapies. The framework is laid out through four guidance documents which build on the FDA’s existing regulatory approach and describe more clearly which products are regulated as drugs, devices and biological products, according to a new FDA release. The documents include new science-based processes for ensuring the safety and effectiveness of such products and a risk-based framework for how it plans to enforce actions against potentially harm...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regenerative Medicine Regulatory/Compliance Source Type: news

Paraplegic rats walk after receiving stem cell therapy
Researchers from the Technion-Israel Institute of Technology found that, after just three weeks, 42 per cent of rodents improved their ability to walk and support their weight. (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Type 1 diabetes: Could modified blood stem cells lead to a cure?
Researchers found that modifying blood stem cells to raise their levels of a T cell-blocking protein called PD-L1 reversed hyperglycemia in diabetic mice. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2017 Category: Consumer Health News Tags: Diabetes Source Type: news

Researchers reverse diabetes in mice by infusing them with blood stem cells
Researchers at Boston Children’s Hospital successfully reversed Type I diabetes in a mouse model using blood stem cells, according to a study published this week in Science Translational Medicine. The researchers used cells that were pre-treated to make more of a protein, PD-L1, which is deficient in mice and people with Type I diabetes. “There’s really a reshaping of the immune system when you inject these cells,” senior investigator Dr. Paolo Fiorina said in prepared remarks. Get the full story at our sister site, Drug Delivery Business News. The post Researchers reverse d...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regenerative Medicine Research & Development Stem Cells Boston Children's Hospital Source Type: news

Brain astrocytes linked to Alzheimer's disease
(University of Eastern Finland) Astrocytes, the supporting cells of the brain, could play a significant role in the pathogenesis of Alzheimer's disease (AD), according to a new study from the University of Eastern Finland. This is the first time researchers discovered a direct association between astrocytes and AD. Published in Stem Cell Reports, the study investigated the brain cell function of familial AD patients by using stem cell technologies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2017 Category: International Medicine & Public Health Source Type: news

Investigating patterns of degeneration in Alzheimer's disease
(Brigham and Women's Hospital) Alzheimer's disease (AD) is known to cause memory loss and cognitive decline, but other functions of the brain can remain intact. The reasons cells in some brain regions degenerate while others are protected is largely unknown. In a paper to be published in Stem Cell Reports, researchers from Brigham and Women's Hospital have found that factors encoded in the DNA of brain cells contribute to the patterns of degeneration, or vulnerability, in AD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2017 Category: International Medicine & Public Health Source Type: news

Stem Cell Therapy Shows Promise for Retinal Degeneration Stem Cell Therapy Shows Promise for Retinal Degeneration
Retinal pigment epithelial cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

F.D.A. Speeds Review of Gene Therapies, Vowing to Target Rogue Clinics
The agency plans to speed approval of treatments to get them to the market faster, signaling the quickened pace of advancements in this field. (Source: NYT Health)
Source: NYT Health - November 17, 2017 Category: Consumer Health News Authors: SHEILA KAPLAN and DENISE GRADY Tags: Stem Cells Genetic Engineering Immunotherapy Food and Drug Administration Source Type: news

US health agency to crack down on risky stem cell offerings
U.S. health authorities say they will crack down on doctors pushing stem cell therapies that pose the gravest risks to patients (Source: ABC News: Health)
Source: ABC News: Health - November 16, 2017 Category: Consumer Health News Tags: Health Source Type: news

Coming Soon-Need Cells? Contest
Creativity RewardedWe are revving up another contest as ourNeuromics Brain Adventure was successful and wow, were people creative.We are expert at finding humanprimary and stem cells so cell cultures are central to the contest. Rules are simple. Affix an image of your favorite cell culture anywhere in your lab and we will email you a $25 Amazon gift card.The contest will run for 3 months and the most creative entry will receive a $500 Visa Gift Card.Simply e-mail your entry to rose@neuromics.com and we will email back the gift card. Multiple entries encouraged. (Source: Neuromics)
Source: Neuromics - November 16, 2017 Category: Neuroscience Tags: astrocyte cultures Astrocyte-Glial-Neuron Co-cultures. endothelial cells needcells Source Type: news

FDA Seeks to Speed Development of'Regenerated' Organs for Medical Use
Source: HealthDay Related MedlinePlus Pages: Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 16, 2017 Category: Consumer Health News Source Type: news

GE, Golden Meditech ink cord blood storage deal
GE Healthcare (NYSE:GE) and Golden Meditech said this week they inked a strategic collaboration deal to provide GE’s integrated and automated digital systems and solutions to Golden Meditech for use in its umbilical cord blood cryopreservation processes. Hong Kong-based Golden Meditech said that umbilical cord blood contains rich hematopoietic stem cells which could facilitate reconstruction of hematopoietic and immune systems with possible applications in stem cell transplantation and other treatments. Through the partnership, Golden Meditech will use fully automated cell processing systems and associated tools...
Source: Mass Device - November 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News GE Healthcare Golden Meditech Holdings Ltd. Source Type: news

FDA Seeks to Speed Development of'Regenerated' Organs for Medical Use
THURSDAY, Nov. 16, 2017 -- Using stem cells to grow new heart tissue, and even whole organs, used to be the stuff of science fiction. But the field of " regenerative medicine " is a reality now -- and the U.S. Food and Drug Administration has its eye... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2017 Category: General Medicine Source Type: news

FDA Warns About Stem Cell Therapies
Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem cell treatments that are illegal and potentially harmful. Here's what to know before you consider stem cell treatment. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - November 16, 2017 Category: Consumer Health News Source Type: news

Unapproved stem cell therapies on the market in Canada
Private clinics are performing unproven stem cell procedures on patients across Canada even though Health Canada says all cell therapies are considered “drugs” and require federal approval before they can be legally used on human patients. (Source: CBC | Health)
Source: CBC | Health - November 16, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

MUSC leads research on potential research treatment
(Medical University of South Carolina) A five-year, $3.8 million grant from the Lupus Foundation of America funds phase 2 of a clinical trial evaluating a treatment using mesenchymal stem cells harvested from donated umbilical cords in patients with lupus resistant to treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Paraplegic rats walk and regain feeling after stem cell treatment
(Frontiers) Paralyzed rats implanted with engineered tissue containing human stem cells were able to walk independently and regained sensory perception in their hind legs and tail. The implanted rats also show some degree of healing in their spinal cords. The research demonstrates the great potential of stem cells to treat spinal cord injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Cincinnati Children ’s invests millions to launch stem cell center
Cincinnati Children ’s Hospital plans to hire additional faculty as it expands facilities and research required to launch a Center for Stem Cell and Organoid Medicine. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 15, 2017 Category: American Health Authors: Barrett J. Brunsman Source Type: news

Immune Checkpoint Found Lacking in Type 1 Diabetes
Boosting levels of a the immunosuppressive protein PD-L1 in blood stem cells halts diabetes in a mouse model of the disease. (Source: The Scientist)
Source: The Scientist - November 15, 2017 Category: Science Tags: Daily News,News & Opinion Source Type: news

Cincinnati Children's launches Center for Stem Cell and Organoid Medicine
(Cincinnati Children's Hospital Medical Center) Seven years ago Cincinnati Children's scientists first used pluripotent stem cells to mimic natural human development and grow working human intestine in a lab. Today medical center doctors can bioengineer the gastrointestinal tissues of sick children to find clues about a child's disease and how to treat it. Cincinnati Children's is building on this early research advancement in personalized medicine by launching the Center for Stem Cell and Organoid Medicine (CuSTOM). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 15, 2017 Category: Biology Source Type: news

Asymmetrex Co-Sponsors Expert Panel Discussion on Stem Cell...
An international audience of regenerative medicine interests has registered to attend a November 30 online expert panel discussion on the current nature and quality of therapeutic tissue stem cell...(PRWeb November 15, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14922009.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 15, 2017 Category: Pharmaceuticals Source Type: news

Astellas sues former research partners, claiming 'usurpation' of stem cell tech
According to a complaint filed Monday in Boston federal court, two scientists worked with Astellas to develop the technology, then secretly applied for a potentially lucrative patent. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 14, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Astellas sues former research partners, claiming 'usurpation' of stem cell tech
According to a complaint filed Monday in Boston federal court, two scientists worked with Astellas to develop the technology, then secretly applied for a potentially lucrative patent. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Max Stendahl Source Type: news

Finding a key to unlock blocked differentiation in microRNA-deficient embryonic stem cells
(University of Alabama at Birmingham) In a study published in Stem Cell Reports, Rui Zhao and colleagues have partly solved a long-unanswered basic question about stem cells -- why are pluripotent stem cells that have mutations to block the production of microRNAs unable to differentiate? (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Monoclonal antibody prevents graft-vs-host disease in bone marrow transplantation model
(Bioscribe) New research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease, a potentially lethal complication of bone marrow stem cell transplantation. CytoDyn is currently enrolling patients in a Phase 2 clinical trial with PRO 140 for the prevention of GvHD in leukemia patients undergoing BMSC transplantation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2017 Category: Cancer & Oncology Source Type: news

Transgenic Stem Cells Lead To A Genuine Miracle Cure
A team of doctors and scientists in Germany and Italy fixed a defective gene in a young boy's skin. They then grew new skin that they used to replace 80% of the skin on his body, saving his life. Two years later, his new skin is amazingly normal. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 13, 2017 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Source Type: news

Researchers Build a Cancer Immunotherapy Without Immune Cells
A team has engineered two stem cell lines into 'synthetic T cells' that destroy breast cancer cells in vitro. (Source: The Scientist)
Source: The Scientist - November 13, 2017 Category: Science Tags: Daily News Source Type: news

Improving the neuron factory -- new modulator of stem cell identity found
(University of Cologne) Since their discovery in 2006, induced pluripotent stem cells are a glimmer of hope for many diseases. But further research of the complex regulation of pluripotent stem cell identity revealed unexpected difficulties. A team of researchers at the Cluster of Excellence CECAD has now found an efficient way to produce neurons from pluripotent stem cells. Their research was published in Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

Medical News Today: How drinking affects brain stem cells
It is well-known that long-term heavy drinking affects the brain, but what does it do to brain stem cells, involved in neural regeneration and maintenance? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2017 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news

Innovative genetic and cellular techniques help identify multiple disease targets
(Society for Neuroscience) Research released today highlights advances in the use of CRISPR-Cas9 and human induced pluripotent stem cell technologies to identify novel therapeutic targets for neurological disorders such as schizophrenia and addiction. The studies were presented at Neuroscience 2017, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 12, 2017 Category: Biology Source Type: news

Scientists replace skin of child with rare genetic disease
For the first time, doctors were able to treat a child who had a life-threatening rare genetic skin disease through a transplant of skin grown using genetically modified stem cells. (Source: CNN.com - Health)
Source: CNN.com - Health - November 10, 2017 Category: Consumer Health News Source Type: news

Understanding the Berlin patient's unexpected cure
(Oregon Health& Science University) Researchers have a new way to understand the much-studied Berlin patient's unexpected cure from HIV and improve outcomes of stem cell transplants for patients with other blood-related diseases such as leukemia and sickle-cell disease. A team at Oregon Health& Science University has shown a species of monkey called Mauritian cynomolgus macaques can successfully receive stem cell transplants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

Grilled-cheese sandwich suspected in young boy ’ s death
New York City officials have closed a preschool in Harlem where a young boy with a severe food allergy died after being given a grilled-cheese sandwich. Investigators were at the preschool on Thursday to review the sequence of events. Elijah Silvera's family said staff knew the 3-year-old was severely allergic to dairy products. Elijah went into […]Related:Controversy erupts over plan to let Pentagon authorize unapproved drugs for battlefield useChuck Norris claims his wife was poisoned during MRI scans, sues for $10 millionGenetically modified skin grown from stem cells saved a 7-year-old boy’s life (Sou...
Source: Washington Post: To Your Health - November 9, 2017 Category: Consumer Health News Source Type: news

Grilled cheese sandwich suspected in young boy ’ s death
New York City officials have closed a preschool in Harlem where a young boy with a severe food allergy died after being given a grilled cheese sandwich. Investigators were at the preschool on Thursday to review the sequence of events. Elijah Silvera's family said staff knew the 3-year-old was severely allergic to dairy products. Elijah went […]Related:Controversy erupts over plan to let Pentagon authorize unapproved drugs for battlefield useChuck Norris claims his wife was poisoned during MRI scans, sues for $10 millionGenetically modified skin grown from stem cells saved a 7-year-old boy’s life (Source: ...
Source: Washington Post: To Your Health - November 9, 2017 Category: Consumer Health News Source Type: news

Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
The drug prevents cytomegalovirus infections and disease in adults previously exposed to the common virus who have received an allogeneic hematopoietic stem cell transplant.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Controversy erupts over plan to let Pentagon authorize unapproved drugs for battlefield use
Should the Pentagon be allowed to authorize the use of unapproved drugs and medical devices on an emergency basis for combat soldiers? That question has sparked a furious battle this week among some of Washington's biggest power players, with the Defense Department and its congressional advocates on one side and the Food and Drug Administration and the […]Related:Genetically modified skin grown from stem cells saved a 7-year-old boy’s lifeNew evidence of brain damage from West Nile virus, scientists sayShe signed up to be a surrogate mother — and unwittingly gave away her own child (Source: Was...
Source: Washington Post: To Your Health - November 9, 2017 Category: Consumer Health News Source Type: news

Controversy erupts over plan to let Pentagon use unapproved drugs on battlefield
Should the Pentagon be allowed to authorize the use of unapproved drugs and medical devices on an emergency basis for combat soldiers? That question has sparked a furious battle this week among some of Washington's biggest power players, with the Defense Department and its congressional advocates on one side and the Food and Drug Administration and the […]Related:Genetically modified skin grown from stem cells saved a 7-year-old boy’s lifeNew evidence of brain damage from West Nile virus, scientists sayShe signed up to be a surrogate mother — and unwittingly gave away her own child (Source: Was...
Source: Washington Post: To Your Health - November 9, 2017 Category: Consumer Health News Source Type: news

FDA OKs Merck drug that prevents infection post-stem cell transplant
(Reuters) - Merck& Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Study led by MIT Portugal faculty and alumni finds how to increase the survival time of stem cells
(MIT Portugal Program) A team of researchers from the Faculty of Medicine at the University of Coimbra, led by Dr. Lino Ferreira, MIT Portugal Program Faculty and researcher at the Center for Neuroscience and Cell Biology (CNC) in collaboration with Langer Lab at MIT (USA), has developed a new technology, which is promising to understand and treat ischemic diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 9, 2017 Category: Biology Source Type: news

Induced pluripotent stem cells show astrocyte-neuron impact on brain pathology in autism
(Elsevier) Using human induced pluripotent stem cells (iPSCs) to model autism spectrum disorder (ASD), researchers at the University of S ã o Paulo, Brazil and University of California, San Diego have revealed for the first time that abnormalities in the supporting cells of the brain, called astrocytes, may contribute to the cause of the disorder. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2017 Category: International Medicine & Public Health Source Type: news

Stem Cell Gene Therapy Replaces Boy's Entire Epidermis Stem Cell Gene Therapy Replaces Boy's Entire Epidermis
Ex vivo gene therapy of epidermal cells from a boy with junctional epidermolysis bullosa enabled grafts to completely replace his epidermis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Dermatology News Source Type: news

FDA Approves Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
KENILWORTH, N.J.--(BUSINESS WIRE) November 9, 2017 --Merck& Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Prevymis (letermovir) once-daily... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

Chuck Norris claims his wife was poisoned during MRI scans, sues for $10 million
Actor and martial artist Chuck Norris is suing several health-care companies, claiming his wife was poisoned by a chemical used during magnetic resonance imaging scans. In a lawsuit filed last week in San Francisco Superior Court, Chuck and Gena Norris argued that gadolinium, a metal used as a contrast agent in MRI scans, caused Gena to sustain gadolinium deposition disease, experiencing “multiple, […]Related:Genetically modified skin grown from stem cells saved a 7-year-old boy’s lifeNew evidence of brain damage from West Nile virus, scientists sayShe signed up to be a...
Source: Washington Post: To Your Health - November 8, 2017 Category: Consumer Health News Source Type: news

Scientists grow replacement skin for boy suffering devastating genetic disorder
Seven-year-old boy suffering illness causing untreatable wounds over 80% of his body has had his skin replaced by new, genetically modified epidermisScientists have grown a replacement, genetically modified skin to cover almost the entire body of a seven-year-old Syrian boy who was suffering from a devastating genetic disorder.The treatment marks a rare and striking success for the field of regenerative medicine, which has been struggling to transform futuristic-sounding science into therapies that make a difference to patients. In the latest trial, the life of the young boy – whose illness had come close to killing ...
Source: Guardian Unlimited Science - November 8, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Genetics Stem cells Medical research Science Biology Source Type: news

Genetically modified skin grown from stem cells saved a 7-year-old boy ’ s life
Scientists reported Wednesday that they genetically modified stem cells to grow skin that they successfully grafted over nearly all of a child's body — a remarkable achievement that could revolutionize treatment of burn victims and people with skin diseases. The research, published in the journal Nature, involved a 7-year-old  boy who suffers from a genetic disease known as junctional epidermolysis […]Related:She signed up to be a surrogate mother — and unwittingly gave away her own childWhite House opioid commission calls for wide-ranging changes to anti-drug policiesScream...
Source: Washington Post: To Your Health - November 8, 2017 Category: Consumer Health News Source Type: news

Sanford Health buys stake in German hospital
Sanford Health is investing in a medical center in Munich, Germany, the first international stake for the growing Sioux Falls, S.D.-based health company. The Star Tribune reports on the move by Sanford, which will become a minority owner of ISAR Klinikum, a hospital it's partnered with before. Sanford, which runs 44 hospitals and nearly 300 clinics across the Midwest, has sent U.S. patients to Germany for access to stem cell or regenerative medicin e treatments. Terms of the deal weren't disclosed,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 8, 2017 Category: American Health Authors: Mark Reilly Source Type: news

Boy is given new skin thanks to gene therapy
(Ruhr-University Bochum) A medical team at the Ruhr-Universit ä t Bochum's burn unit and the Center for Regenerative Medicine at the University of Modena (Italy) were the first ever to successfully treat a child suffering from extensive skin damage using transplants derived from genetically modified stem cells. The boy is a so-called butterfly child: he suffers from epidermolysis bullosa, a genetic skin disease that had destroyed approximately 80 percent of his epidermis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Urgent news about syndrome zero
I have urgent news. I consider this to be the biggest health crisis of all time. As a matter of fact, it’s a rapidly growing pandemic spreading around the world. When we look at the rate of new incidences, it’s only a matter of time before every man, woman and child on the planet will be affected. But what’s truly alarming is that it’s at the very root of every chronic disease plaguing our modern world. Cancer Heart disease Diabetes Obesity Alzheimer’s I named this emerging new threat Syndrome Zero. And while mainstream medicine has yet to connect the dots like I have, evidence that supports...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Natural Cures Alzheimer's Cancer Chronic diseases diabetes heart disease obesity Syndrome Zero Source Type: news